ActivePhase 2Phase 3ACTRN12609000748213

A targeted community program of vitamin D treatment to reduce hospital admissions for falls, fractures and other disorders

A randomised controlled placebo-controlled study to evaluate the effects of vitamin D treatment on reducing hospital admissions for falls, fractures and other disorders in elderly women


Sponsor

Professor RL Prince

Enrollment

660 participants

Start Date

Feb 1, 2009

Study Type

Interventional

Conditions

Summary

This is a nine-month randomised controlled study to evaluate the effects of vitamin D 150,000 IU per three months on risk of falling, serum vitamin D levels, mobility function and muscle strength in women aged 70 years and over at a community setting.


Eligibility

Sex: FemalesMin Age: 70 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether a community-based vitamin D treatment program can reduce hospital admissions for falls, fractures, and related conditions in older women. It is open to women aged 70 and older who are registered with a general practitioner in the Perth area.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

150,000 IU vitamin D (cholecalciferol) taken orally as 3 capsules at three clinic visits three months apart; lifestyle advice on physical activity and calcium intake given at baseline through an infor

150,000 IU vitamin D (cholecalciferol) taken orally as 3 capsules at three clinic visits three months apart; lifestyle advice on physical activity and calcium intake given at baseline through an information sheet administered by trained research assistants


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000748213


Related Trials